ArchPoint Investors’s Allergan Inc AGN Stock Holding History

ArchPoint Investors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,560	Closed	-$473K	–	148
2015 Q2	$473K	Buy	+1,560	New	+$473K	0.3%	52

Other funds holding AGN

Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return

Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return

Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return

Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return

Pergamon Offshore Advisors New York $91.8M AUM 13.29% 1-Year Est. Return

Asset Advisors Corp Augusta, Georgia $575M AUM 14.42% 1-Year Est. Return

Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return

Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return

Liberty Capital Management Birmingham, Michigan $582M AUM

ArchPoint Investors's AGN Position: Q3 2015 in Review

ArchPoint Investors sold out of Allergan Inc (AGN) in Q3 2015, closing a stake of 1,560 shares — an estimated $473K sold.

ArchPoint Investors first reported a position in AGN in Q2 2015 and held it in 1 quarter. The position peaked at $473K in Q2 2015. 27 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

ArchPoint Investors reported no remaining Allergan Inc position as of Q3 2015 after selling out during the quarter.
ArchPoint Investors sold 1,560 Allergan Inc shares in Q3 2015, an estimated $473K.
ArchPoint Investors first reported a position in Allergan Inc in Q2 2015 and held it in 1 quarter.
ArchPoint Investors's Allergan Inc position peaked at $473K in Q2 2015.
27 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2015.

Based on ArchPoint Investors's 13F filing for Q3 2015, filed 12 Nov 2015.